FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890928699> ?p ?o ?g. }

• W2890928699 endingPage "108" @default.
• W2890928699 startingPage "105" @default.
• W2890928699 abstract "In last years, following the increased canine life expectancy and the rising attention pet-owners devote to their animals, several authors have carried on investigations concerning new techniques to early identify canine prostatic disorders that might affect the dog's quality of life. Prostatic disorders often have an asymptomatic onset and their early diagnosis is difficult: hence, they are usually identified at an advanced stage, only. Traditionally, the diagnosis of prostatic disorders is based on noninvasive tools, such as transrectal and abdominal palpation, seminal or prostatic fluid evaluation, and urinalysis and imaging. On the other hand, a definite diagnosis of prostatic abnormalities could be achieved through prostatic parenchyma Fine Needle Aspiration (FNA) or biopsy. However, these investigations are performed rarely because of their invasiveness. Thus, several authors investigated canine serum biomarkers in order to achieve an earlier diagnostic timing and to apply therapeutic strategies for better outcomes. The Canine Prostatic Specific Esterase (CPSE) has been identified as a suitable biomarker to be included in a prostate health screening program, following the model of prostate-specific antigen (PSA) in human medicine. A higher CPSE in dogs suffering from several prostatic diseases, such as benign prostatic hyperplasia, bacterial prostatitis, or prostatic carcinoma, was reported in literature. Thanks to the potential usefulness in clinical practice, further studies should investigate the potential role of CPSE in monitoring the medical treatment success in the male reproductive system. Moreover, the spreading availability of serum biomarkers, easily carried out on blood samples in clinical practice, could assure a more accurate evaluation of the actual prevalence of prostatic disorders. The CPSE is actually recognized as a promising diagnostic tool for the detection of prostatic disorders in a prostate health screening program, in order to properly select those patients requiring further more accurate and expensive diagnostic investigations." @default.
• W2890928699 created "2018-09-27" @default.
• W2890928699 creator A5015226125 @default.
• W2890928699 creator A5021139185 @default.
• W2890928699 creator A5051052058 @default.
• W2890928699 creator A5064709393 @default.
• W2890928699 date "2018-12-01" @default.
• W2890928699 modified "2023-10-14" @default.
• W2890928699 title "Advances in Prostatic Diagnostics in Dogs: The Role of Canine Prostatic Specific Esterase in the Early Diagnosis of Prostatic Disorders" @default.
• W2890928699 cites W1480661704 @default.
• W2890928699 cites W1510698102 @default.
• W2890928699 cites W1567390290 @default.
• W2890928699 cites W1608099500 @default.
• W2890928699 cites W1806835095 @default.
• W2890928699 cites W1814618648 @default.
• W2890928699 cites W1908316619 @default.
• W2890928699 cites W1989457463 @default.
• W2890928699 cites W1998811449 @default.
• W2890928699 cites W1998999565 @default.
• W2890928699 cites W2003143707 @default.
• W2890928699 cites W2007156497 @default.
• W2890928699 cites W2013886049 @default.
• W2890928699 cites W2019305882 @default.
• W2890928699 cites W2026413610 @default.
• W2890928699 cites W2034113164 @default.
• W2890928699 cites W2036149636 @default.
• W2890928699 cites W2045107953 @default.
• W2890928699 cites W2049863849 @default.
• W2890928699 cites W2059619548 @default.
• W2890928699 cites W2068134208 @default.
• W2890928699 cites W2069259979 @default.
• W2890928699 cites W2069567577 @default.
• W2890928699 cites W2077369152 @default.
• W2890928699 cites W2079756456 @default.
• W2890928699 cites W2090566125 @default.
• W2890928699 cites W2095320549 @default.
• W2890928699 cites W2105826721 @default.
• W2890928699 cites W2111002040 @default.
• W2890928699 cites W2119209096 @default.
• W2890928699 cites W2146204617 @default.
• W2890928699 cites W2160138180 @default.
• W2890928699 cites W2160872139 @default.
• W2890928699 cites W2162464327 @default.
• W2890928699 cites W2255748524 @default.
• W2890928699 cites W2281307694 @default.
• W2890928699 cites W2324029910 @default.
• W2890928699 cites W2330292521 @default.
• W2890928699 cites W2340975198 @default.
• W2890928699 cites W2438121176 @default.
• W2890928699 cites W2527420870 @default.
• W2890928699 cites W2581790641 @default.
• W2890928699 cites W2622929534 @default.
• W2890928699 cites W2624423029 @default.
• W2890928699 cites W2707076837 @default.
• W2890928699 cites W2732333967 @default.
• W2890928699 cites W2756126667 @default.
• W2890928699 cites W2768485132 @default.
• W2890928699 cites W53877061 @default.
• W2890928699 doi "https://doi.org/10.1053/j.tcam.2018.09.002" @default.
• W2890928699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30502858" @default.
• W2890928699 hasPublicationYear "2018" @default.
• W2890928699 type Work @default.
• W2890928699 sameAs 2890928699 @default.
• W2890928699 citedByCount "19" @default.
• W2890928699 countsByYear W28909286992019 @default.
• W2890928699 countsByYear W28909286992020 @default.
• W2890928699 countsByYear W28909286992021 @default.
• W2890928699 countsByYear W28909286992022 @default.
• W2890928699 countsByYear W28909286992023 @default.
• W2890928699 crossrefType "journal-article" @default.
• W2890928699 hasAuthorship W2890928699A5015226125 @default.
• W2890928699 hasAuthorship W2890928699A5021139185 @default.
• W2890928699 hasAuthorship W2890928699A5051052058 @default.
• W2890928699 hasAuthorship W2890928699A5064709393 @default.
• W2890928699 hasBestOaLocation W28909286991 @default.
• W2890928699 hasConcept C121608353 @default.
• W2890928699 hasConcept C126322002 @default.
• W2890928699 hasConcept C126894567 @default.
• W2890928699 hasConcept C142724271 @default.
• W2890928699 hasConcept C2776235491 @default.
• W2890928699 hasConcept C2780101318 @default.
• W2890928699 hasConcept C2780524745 @default.
• W2890928699 hasConcept C2911054351 @default.
• W2890928699 hasConcept C2911124710 @default.
• W2890928699 hasConcept C71924100 @default.
• W2890928699 hasConceptScore W2890928699C121608353 @default.
• W2890928699 hasConceptScore W2890928699C126322002 @default.
• W2890928699 hasConceptScore W2890928699C126894567 @default.
• W2890928699 hasConceptScore W2890928699C142724271 @default.
• W2890928699 hasConceptScore W2890928699C2776235491 @default.
• W2890928699 hasConceptScore W2890928699C2780101318 @default.
• W2890928699 hasConceptScore W2890928699C2780524745 @default.
• W2890928699 hasConceptScore W2890928699C2911054351 @default.
• W2890928699 hasConceptScore W2890928699C2911124710 @default.
• W2890928699 hasConceptScore W2890928699C71924100 @default.
• W2890928699 hasIssue "4" @default.
• W2890928699 hasLocation W28909286991 @default.
• W2890928699 hasLocation W28909286992 @default.

• next